JACOBS LEVY EQUITY MANAGEMENT, INC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 84 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$511,000
-65.4%
60,008
-64.0%
0.00%
-72.7%
Q1 2021$1,476,000
-41.0%
166,726
-18.1%
0.01%
-50.0%
Q4 2020$2,503,000
+5.8%
203,644
-29.9%
0.02%
-12.0%
Q3 2020$2,366,000
+34.6%
290,698
+58.7%
0.02%
+31.6%
Q2 2020$1,758,000
+207.9%
183,120
+118.1%
0.02%
+171.4%
Q1 2020$571,000
+79.6%
83,979
+293.2%
0.01%
+133.3%
Q4 2019$318,000
+43.2%
21,360
-1.4%
0.00%0.0%
Q3 2019$222,000
-11.6%
21,660
+45.0%
0.00%
-40.0%
Q1 2016$251,00014,9380.01%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders